- Home
- GANX vs ZCMD Comparison
GANX vs ZCMD Comparison
Compare GANX & ZCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GANX
- ZCMD
- Stock Information
- Founded
- GANX 2017
- ZCMD 2012
- Country
- GANX United States
- ZCMD China
- Employees
- GANX N/A
- ZCMD N/A
- Industry
- GANX Biotechnology: Pharmaceutical Preparations
- ZCMD Other Consumer Services
- Sector
- GANX Health Care
- ZCMD Real Estate
- Exchange
- GANX Nasdaq
- ZCMD Nasdaq
- Market Cap
- GANX 41.9M
- ZCMD 35.3M
- IPO Year
- GANX 2021
- ZCMD 2020
- Fundamental
- Price
- GANX $2.27
- ZCMD $1.39
- Analyst Decision
- GANX Strong Buy
- ZCMD
- Analyst Count
- GANX 5
- ZCMD 0
- Target Price
- GANX $7.60
- ZCMD N/A
- AVG Volume (30 Days)
- GANX 218.6K
- ZCMD 3.1K
- Earning Date
- GANX 03-25-2025
- ZCMD 01-01-0001
- Dividend Yield
- GANX N/A
- ZCMD N/A
- EPS Growth
- GANX N/A
- ZCMD N/A
- EPS
- GANX N/A
- ZCMD N/A
- Revenue
- GANX N/A
- ZCMD $17,406,104.00
- Revenue This Year
- GANX N/A
- ZCMD N/A
- Revenue Next Year
- GANX N/A
- ZCMD N/A
- P/E Ratio
- GANX N/A
- ZCMD N/A
- Revenue Growth
- GANX N/A
- ZCMD 1.01
- 52 Week Low
- GANX $0.89
- ZCMD $1.00
- 52 Week High
- GANX $5.19
- ZCMD $4.60
- Technical
- Relative Strength Index (RSI)
- GANX 47.71
- ZCMD 44.07
- Support Level
- GANX $2.30
- ZCMD $1.36
- Resistance Level
- GANX $2.81
- ZCMD $1.50
- Average True Range (ATR)
- GANX 0.25
- ZCMD 0.06
- MACD
- GANX -0.03
- ZCMD 0.01
- Stochastic Oscillator
- GANX 35.33
- ZCMD 29.41
About GANX Gain Therapeutics Inc.
Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across, several therapeutics areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. The company derives revenues from collaboration and licensing agreements.
About ZCMD Zhongchao Inc.
ZHONGCHAO Inc is a Cayman Islands-based provider of healthcare information, education, and training services. It provides services to healthcare professionals and the public in China. It offers online and onsite health information services, healthcare education programs, and healthcare training products, consisting of clinical practice training, open classes of popular medical topics, interactive case studies, academic conferences and workshops, continuing education courses, and articles and short videos with educational healthcare content.